Hählen K - Search Results

1

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.

van der Velden VH, Jacobs DC, Wijkhuijs AJ, Comans-Bitter WM, Willemse MJ, Hählen K, Kamps WA, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: hahlen k. Leukemia. 2002 Aug;16(8):1432-6. doi: 10.1038/sj.leu.2402636. Leukemia. 2002. PMID: 12145681

2

Limited combinatorial repertoire of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias.

Breit TM, Wolvers-Tettero IL, Hählen K, van Wering ER, van Dongen JJ. Breit TM, et al. Among authors: hahlen k. Leukemia. 1991 Feb;5(2):116-24. Leukemia. 1991. PMID: 1826936

3

Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease.

Breit TM, Wolvers-Tettero IL, Hählen K, van Wering ER, van Dongen JJ. Breit TM, et al. Among authors: hahlen k. Leukemia. 1991 Dec;5(12):1076-86. Leukemia. 1991. PMID: 1837811

4

Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin.

Beishuizen A, Hählen K, Hagemeijer A, Verhoeven MA, Hooijkaas H, Adriaansen HJ, Wolvers-Tettero IL, van Wering ER, van Dongen JJ. Beishuizen A, et al. Among authors: hahlen k. Leukemia. 1991 Aug;5(8):657-67. Leukemia. 1991. PMID: 1909409

5

In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.

Klumper E, Pieters R, Kaspers GJ, Huismans DR, Loonen AH, Rottier MM, van Wering ER, van der Does-van den Berg A, Hählen K, Creutzig U, et al. Klumper E, et al. Among authors: hahlen k. Leukemia. 1995 Nov;9(11):1864-9. Leukemia. 1995. PMID: 7475276

6

Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.

van Wering ER, Beishuizen A, Roeffen ET, van der Linden-Schrever BE, Verhoeven MA, Hählen K, Hooijkaas H, van Dongen JJ. van Wering ER, et al. Among authors: hahlen k. Leukemia. 1995 Sep;9(9):1523-33. Leukemia. 1995. PMID: 7658722

7

Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.

Adriaansen HJ, Jacobs BC, Kappers-Klunne MC, Hählen K, Hooijkaas H, van Dongen JJ. Adriaansen HJ, et al. Among authors: hahlen k. Leukemia. 1993 Mar;7(3):472-81. Leukemia. 1993. PMID: 7680403

8

Drug combination testing in acute lymphoblastic leukemia using the MTT assay.

Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk I, Hählen K, Van Wering ER. Kaspers GJ, et al. Among authors: hahlen k. Leuk Res. 1995 Mar;19(3):175-81. doi: 10.1016/0145-2126(94)00126-u. Leuk Res. 1995. PMID: 7700079

9

Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.

Beishuizen A, Verhoeven MA, van Wering ER, Hählen K, Hooijkaas H, van Dongen JJ. Beishuizen A, et al. Among authors: hahlen k. Blood. 1994 Apr 15;83(8):2238-47. Blood. 1994. PMID: 8161789 Free article.

10

Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.

Beishuizen A, Verhoeven MA, Hählen K, van Wering ER, van Dongen JJ. Beishuizen A, et al. Among authors: hahlen k. Leukemia. 1993 Jun;7(6):60-3. Leukemia. 1993. PMID: 8315958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters